Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) EBIT Margin (2021 - 2025)

Rxo (RXO) has disclosed EBIT Margin for 5 consecutive years, with 2.86% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin fell 142.0% year-over-year to 2.86%, compared with a TTM value of 1.38% through Dec 2025, down 15.0%, and an annual FY2025 reading of 1.38%, down 15.0% over the prior year.
  • EBIT Margin was 2.86% for Q4 2025 at Rxo, down from 0.49% in the prior quarter.
  • Across five years, EBIT Margin topped out at 4.73% in Q2 2022 and bottomed at 2.86% in Q4 2025.
  • Average EBIT Margin over 5 years is 0.52%, with a median of 0.5% recorded in 2023.
  • The sharpest move saw EBIT Margin tumbled -423bps in 2022, then skyrocketed 152bps in 2023.
  • Year by year, EBIT Margin stood at 4.14% in 2021, then plummeted by -102bps to 0.09% in 2022, then surged by 1703bps to 1.43% in 2023, then crashed by -201bps to 1.44% in 2024, then plummeted by -99bps to 2.86% in 2025.
  • Business Quant data shows EBIT Margin for RXO at 2.86% in Q4 2025, 0.49% in Q3 2025, and 2.09% in Q1 2025.